Elder Pharmaceuticals & GNOSIS in licensing deal

1971 Investors following Elder Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Elder Pharmaceuticals & GNOSIS in licensing deal

Elder Pharmaceuticals Ltd, a Mumbai based Rs 500 crore pharmaceutical company has recently signed an in-licensing agreement with GNOSIS S.p.A, Italy.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Elder Pharma to increase its stake in NeutraHealth to 29% Elder Pharma:Forbes Asia’s 200 Best under a mn cos Elder Pharma quarter sales soar by 21.34% yoy to Rs 132cr ALSO READ See latest News about Elder Pharma See previous management interviews See what other Experts & Brokerages are saying about Elder Pharma Elder Pharma BSE | NSE 25/05/12 Are Mutual Funds betting on Elder Pharma?

Elder Pharmaceuticals Ltd, a Mumbai based Rs 500 crore pharmaceutical company has recently signed an in-licensing agreement with GNOSIS S.p.A , Italy. Under the terms of the agreement, GNOSIS has licensed an anti-osteoarthritic nutritional supplement S-Adenosyl Methionine (SAMe), and will supply the product in finished form to be marketed in India by Elder Pharma under the trademark SAMPURE. GNOSIS is an advanced biotech company based in Italy & is committed to advanced biotechnology & innovative processes. Its range of products includes nutraceuticals in the management of chronic disorders like osteoarthritis, osteoporosis, liver disorders, etc.

Osteoarthritis is one of the most prevalent joint disorders, especially in middle-aged & elderly people. Because the proportion of the older people in our population is continually rising, osteoarthritis is becoming an increasingly important health problem. Currently the market for anti-arthritic products in India is around Rs. 600 crores & is showing a good growth. SAMe is a stabilized form of S-Adenosyl Methionine, a chemical produced naturally in all animals. In the human body SAMe is known to be essential to at least 35 biochemical processes & is available as a dietary supplement in the US market since 1999.

Elder Pharmaceuticals is a mid-sized pharma company, which manufactures & markets ethical medicines as well as consumer products such as Tiger Balm, FairOne, etc. Apart from its own brands like Shelcal, it has a number of in-licensing arrangements with more than 25 international healthcare companies, wherein, it manufactures & markets those products under the license of the originator company. Its principal therapeutic areas concern women healthcare, pain management, nutraceuticals, cardio-vascular and dermatological products.  

Sourced From: Corporate Voice|Weber Shandwick